Related Experiment Video
Updated: Oct 1, 2025

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Clinical characteristics of plastic bronchitis in children: a retrospective analysis of 43 cases
Jing-Jing Huang1, Xiao-Qing Yang2, Zhi-Qiang Zhuo1
1Third ward, Xiamen Children's Hospital/Children's Hospital of Fudan University Xiamen Branch, Xiamen, 361006, Fujian, China.
Insights
Plastic bronchitis (PB) in children often follows respiratory infections and presents with fever and cough. Early bronchoscopic removal of airway casts is an effective treatment for this condition.
Area of Science:
- Pediatric Pulmonology
- Respiratory Medicine
- Clinical Case Series
Background:
- Plastic bronchitis (PB) diagnosis is increasing, necessitating more research.
- Limited studies exist on pediatric PB clinical characteristics, diagnosis, and treatment.
Purpose of the Study:
- To explore the clinical characteristics of pediatric plastic bronchitis.
- To enhance understanding of diagnosis and treatment strategies for pediatric PB.
Main Methods:
- Retrospective analysis of clinicopathological data from 43 children with PB.
- Data collected from Xiamen Children's Hospital and Women and Children's Hospital (Dec 2016-Dec 2019).
Main Results:
- Common symptoms included cough, fever (>40°C in 25), and shortness of breath.
- Lung imaging revealed consolidation, atelectasis, and pleural effusion; infections often caused by adenovirus or Mycoplasma pneumoniae.
- Bronchoscopic cast removal, anti-infective therapy, and corticosteroids/gamma globulin led to recovery in most patients.
Conclusions:
- Pediatric PB is often secondary to respiratory infections and progresses rapidly.
- Key manifestations include hyperpyrexia, cough, and dyspnea.
- Early bronchoscopic intervention for cast removal is an effective treatment for pediatric PB.
Background:
With an increase in the diagnosis of plastic bronchitis (PB) cases, to enhance paediatricians' knowledge and add to the few existing studies, we explored the clinical characteristics, diagnosis, and treatment of PB in children.
Methods:
The clinicopathological data of 43 children admitted to the Xiamen Children's Hospital and the Women and Children's Hospital, affiliated to the Xiamen University from December 2016 to December 2019, were retrospectively analysed.
Results:
All the children had cough, with 41 of them having associated fever. A peak temperature > 40 ℃ was observed in 25 children. Twenty-six children had shortness of breath, 27 had reduced respiratory sounds on the affected side, and 35 had audible moist rales on the affected side. Lactate dehydrogenase in all children increased to different degrees, and 29 had elevated D-dimer and fibrinogen degradation products. Lung imaging showed pulmonary consolidation and atelectasis, mainly in the bilateral lower lung lobes, in all the children. However, 31 had pleural effusion, mainly a small parapneumonic effusion. The infections were mainly caused by adenovirus and Mycoplasma pneumoniae. The casts in all 43 children were sucked or clamped out under bronchoscopy, and 10 were found to have type I PB on pathological examination. All children were treated with anti-infective therapy in addition to bronchoscopic cast removal. Thirty-one children were treated with methylprednisolone, and 16 with gamma globulin. Except for one child who was non-adherent to treatment, all other children showed improvement, or were cured and discharged from the hospital. Follow-up lung imaging at 3 months revealed that the lungs were fully re-expanded in 40 children. At the 6-month follow-up, six children had small airway lesions, four had obliterative bronchiolitis, and one had bronchiectasis.
Conclusions:
Paediatric PB often occurs secondary to respiratory tract infections and progresses rapidly, with hyperpyrexia, cough, and shortness of breath as the main clinical manifestations. Pulmonary consolidation, atelectasis, and pleural effusion are seen on lung imaging, and early bronchoscopy and removal of casts in the trachea and bronchi are effective treatment options.
Related Concept Videos
Pulmonary Cycle: Exhalation
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:

